Initiation and propagation of coagulation from tissue factor-bearing cell monolayers to plasma: Initiator cells do not regulate spatial growth rate

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 2, 2005, Pages 321-331

  Ovanesov, Mikhail V ^a,e   Ananyeva, N M ^a,e   Panteleev, M A ^b   Ataullakhanov, F I ^b,c,d   Saenko, E L ^a,e  

^a HOLLAND LABORATORY   (United States)

^b NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

^d INSTITUTE OF THEORETICAL AND EXPERIMENTAL BIOPHYSICS   (Russian Federation)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Factor VIII; Procoagulant activity; Regulation; Thrombus growth

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; LIPOCORTIN 5; PROCOAGULANT; THROMBOPLASTIN; CANCER PROCOAGULANT; CYSTEINE PROTEINASE; PHOSPHOLIPID; THROMBIN; TUMOR PROTEIN;

ARTICLE; BLOOD CLOTTING; CELL ASSAY; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; GROWTH RATE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG FIBROBLAST; MACROPHAGE; PLASMA CELL; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; THROMBOGENESIS; BIOSYNTHESIS; CELL FUNCTION; CYTOLOGY; FIBROBLAST; KINETICS; MICROSCOPY; PATHOLOGY; PHYSIOLOGY; THROMBOSIS; VASCULAR ENDOTHELIUM;

BLOOD COAGULATION; CELL PHYSIOLOGY; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FIBROBLASTS; HUMANS; KINETICS; MACROPHAGES; MICROSCOPY, VIDEO; MYOCYTES, SMOOTH MUSCLE; NEOPLASM PROTEINS; PHOSPHOLIPIDS; THROMBIN; THROMBOPLASTIN; THROMBOSIS;

EID: 20844432399     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01128.x     Document Type: Article

References (36)

1. Contrino J, Hair GA, Schmeizl MA, Rickles FR, Kreutzer DL. In situ characterization of antigenic and functional tissue factor expression in human tumors utilizing monoclonal antibodies and recombinant factor VIIa as probes. Am J Pathol 1994; 145: 1315-22.
2. Hatakeyama K, Asada Y, Marutsuka K, Sato Y, Kamikubo Y, Sumiyoshi A. Localization and activity of tissue factor in human aortic atherosclerotic lesions. Atherosclerosis 1997; 133: 213-19.
3. Osterud B, Tindall A, Brox JH, Olsen JO. Thromboplastin content in the vessel walls of different arteries and organs of rabbits. Thromb Res 1986; 42: 323-9.
4. Rodgers GM, Greenberg CS, Shuman MA. Characterization of the effects of cultured vascular cells on the activation of blood coagulation. Blood 1983; 61: 1155-62.
5. Kirchhofer D, Sakariassen KS, Clozel M, Tschopp TB, Hadvary P, Nemerson Y, Baumgartner HR. Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditions. Blood 1993; 81: 2050-8.
6. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134: 1087-97.
7. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-43.
8. Flossel C, Luther T, Muller M, Albrecht S, Kasper M. Immunohistochemical detection of tissue factor (TF) on paraffin sections of routinely fixed human tissue. Histochemistry 1994; 101: 449-53.
9. Ardissino D, Merlini PA, Bauer KA, Bramucci E, Ferrario M, Coppola R, Fetiveau R, Lucreziotti S, Rosenberg RD, Mannucci PM. Thrombogenic potential of human coronary atherosclerotic plaques. Blood 2001; 98: 2726-9.
10. Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med 1996; 2: 209-15.
11. Pieters J, Willems G, Hemker HC, Lindhout T. Inhibition of factor IXa and factor Xa by antithrombin III/heparin during factor X activation. J Biol Chem 1988; 263: 15313-18.
12. Monroe DM, Hoffman M, Roberts HR. Transmission of a procoagulant signal from tissue factor-bearing cell to platelets. Blood Coagul Fibrinolysis 1996; 7: 459-64.
13. Hathcock JJ, Nemerson Y. Platelet deposition inhibits tissue factor activity: in vitro clots are impermeable to factor Xa. Blood 2004; 104: 123-7.
14. Mosesson MW. Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation. Thromb Haemost 2003; 89: 9-12.
15. Nemerson Y, Turitto VT. The effect of flow on hemostasis and thrombosis. Thromb Haemost 1991; 66: 272-6.
16. Balasubramanian V, Grabowski E, Bini A, Nemerson Y. Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: realtime fluorescence images of thrombus formation and propagation under defined flow conditions. Blood 2002; 100: 2787-92.
17. Falati S, Gross P, Merrill-Skoloff G, Furie BC, Furie B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med 2002; 8: 1175-81.
18. Ovanesov MV, Krasotkina JV, Ul'yanova LI, Abushinova KV, Plyushch OP, Domogatskii SP, Vorob'ev AI, Ataullakhanov FI. Hemophilia A and B are associated with abnormal spatial dynamics of clot growth. Biochim Biophys Acta 2002; 1572: 45-57.
19. Saenko EL, Shima M, Gilbert GE, Scandella D. Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition. J Biol Chem 1996; 271: 27424-31.
20. Ananyeva NM, Kouiavskaia DV, Shima M, Saenko EL. Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque. Blood 2002; 99: 4475-85.
21. Taube J, McWilliam N, Luddington R, Byrne CD, Baglin T. Activated protein C resistance: effect of platelet activation, platelet-derived microparticles, and atherogenic lipoproteins. Blood 1999; 93: 3792-7.
22. Korotina NG, Ovanesov MV, Plyusch OP, Kopylov KG, Lopatina EG, Saenko EL, Butylin AA, Ataullakhanov FI. Spontaneous clots in normal plasma and plasma of patients with hemophilia A. Haematol Transfusial (Russia) 2002; 47: 26-30.
23. Muller AD, van Deijk WA, Devilee PP, Dam-Mieras MC, Hemker HC. The activity state of factor VII in plasma, two pathways for the cold promoted activation of factor VII. Br J Haematol 1986; 62: 367-77.
24. Hemker HC, Giesen PL, Ramjee M, Wagenvoord R, Beguin S. The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thromb Haemost 2000; 83: 589-91.
25. Nagashima H. Studies on the different modes of action of the anticoagulant protease inhibitors DX-9065a and Argatroban. I. Effects on thrombin generation. J Biol Chem 2002; 277: 50439-44.
26. Ovanesov MV, Lopatina EG, Saenko EL, Ananyeva NM, Ul'yanova LI, Plyushch OP, Butilin AA, Ataullakhanov FI. Effect of factor VIII on tissue factor-initiated spatial clot growth. Thromb Haemost 2003; 89: 235-42.
27. Zwaginga JJ, de Boer HC, Ijsseldijk MJ, Kerkhof A, Muller-Berghaus G, Gruhlichhenn J, Sixma JJ, de Groot PG. Thrombogenicity of vascular cells. Comparison between endothelial cells isolated from different sources and smooth muscle cells and fibroblasts. Arteriosclerosis 1990; 10: 437-48.
28. Kerlin B, Cooley BC, Isermann BH, Hernandez I, Sood R, Zogg M, Hendrickson SB, Mosesson MW, Lord S, Weiler H. Cause-effect relation between hyperfibrinogenemia and vascular disease. Blood 2004; 103: 1728-34.
29. Shi J, Gilbert GE. Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites. Blood 2003; 101: 2628-36.
30. Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vase Biol 2002; 22: 1381-9.
31. Monroe DM, Roberts HR, Hoffman M. Platelet procoagulant complex assembly in a tissue factor-initiated system. Br J Haematol 1994; 88: 364-71.
32. Ataullakhanov FI, Guriia GT. Spatial aspects of the dynamics of blood coagulation. I. Hypothesis. Biofizika 1994; 39: 89-96.
33. Dewerchin MEL, Singh I, Grailly S, Saint-Remy JM, Collen D, Jacquemin M. Inhibition of factor VIII with a partially inhibitory human recombinant monoclonal antibody prevents thrombotic events in a transgenic model of type II HBS antithrombin deficiency in mice. J Thromb Haemost 2004; 2: 77-84.
34. Kjalke M, Monroe DM, Hoffman M, Oliver JA, Ezban M, Roberts HR. Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation. Thromb Haemost 1998; 80: 578-84.
35. Kirchhofer D, Tschopp TB, Baumgartner HR. Active site-blocked factors VIIa and IXa differentially inhibit fibrin formation in a human ex vivo thrombosis model. Arterioscler Thromb Vase Biol 1995; 15: 1098-106.
36. Refino CJ, Jeet S, DeGuzman L, Bunting S, Kirchhofer D. A human antibody that inhibits factor IX/IXa function potently inhibits arterial thrombosis without increasing bleeding. Arterioscler Thromb Vase Biol 2002; 22: 517-22.